Pharmaceuticals, Biotechnology and Life Sciences
– Preliminary Anti-tumor Activity Observed in Initial Diffuse-type TGCT Patients Treated with DCC-3014 in Ongoing Phase 1 Study – –…
Phase II Study of DM199 in Chronic Kidney Disease Commences Screening REMEDY Phase II Study of DM199 in Acute Ischemic…
Company Advancing ALPN-101 into a Phase 1/2 Acute Graft versus Host Disease Study (BALANCE) Phase 1 Study (NEON-1) of Lead…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Dicerna™ Pharmaceuticals, Inc. (Nasdaq: DRNA) (the “Company” or “Dicerna”), a leading developer of investigational ribonucleic acid interference (RNAi)…
VICTORIA, British Columbia–(BUSINESS WIRE)–Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (“Aurinia” or the “Company”), a late-stage clinical biopharmaceutical company…
MENLO PARK, Calif.–(BUSINESS WIRE)–Dermira, Inc. (NASDAQ: DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering…
Full-Year Revenue Increased 14.5% to $34 Million Fourth Quarter Revenue Up 20.0% to $8 Million LANCASTER, Calif.–(BUSINESS WIRE)–Simulations Plus, Inc.…
– Completion of patient enrollment in Phase 3 clinical study of omidubicel expected by year-end; Topline data anticipated in first…
AmeriHealth Caritas Offers Ideas for Reducing Childhood Immunization Disparities PHILADELPHIA–(BUSINESS WIRE)–#AmeriHealthCaritas–According to research by the Centers for Disease Control and…
Three multimedia platforms spanning oncology, cannabis technology and practice management receive prestigious honors for editorial content and design CRANBURY, N.J.–(BUSINESS…